The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R06 | Antihistamines for systemic use | |
| 3 | R06A | Antihistamines for systemic use | |
| 4 | R06AX | Other antihistamines for systemic use | |
| 5 | R06AX26 | Fexofenadine |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 120 mg |
| Active Ingredient | Description | |
|---|---|---|
| Fexofenadine |
Fexofenadine is a non-sedating H1 antihistamine. Fexofenadine is a pharmacologically active metabolite of terfenadine. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALLEGRA ALLERGY Film coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| FEXOFAST Film-coated tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| TELFAST Film-coated tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
